Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2015 Jan 21;1848(4):1014–1022. doi: 10.1016/j.bbamem.2015.01.011

Figure 5. Lipid-mixing inhibition by 4E10 antibody.

Figure 5

CpreTM-primed vesicles were incubated with increasing amounts of MAb4E10 prior to the addition of target vesicles (circles). Cala-primed vesicles were used as negative control to probe the specificity of the process (squares). The dotted line begins at the paratope-to-peptide ratio of 0.5:1. Plotted values are means±SD of three experiments.